Xtant Medical

Xtant Medical Postpones Release of Third Quarter 2017 Financial Results

BELGRADE, Mont., Nov. 09, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it has postponed the release of its third quarter 2017 financial results, originally scheduled for Wednesday, November 8, 2017, and conference call, originally scheduled for Thursday, November 9, 2017. The Company now plans to release its third quarter 2017 financial results in conjunction with the filing of its 10-Q which is currently expected to occur by November 20, 2017. About Xtant Medical
Xtant Medical develops, manufactures and markets regenerative medicine products and medical devi…